lipoxygenase inhibitors

Preferred Label : lipoxygenase inhibitors;

MeSH definition : Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES.;

MeSH synonym : inhibitors, lipoxygenase; Lipoxygenase Inhibitor; Inhibitor, Lipoxygenase;

MeSH hyponym : arachidonate 5-Lipoxygenase inhibitors; arachidonate 12-Lipoxygenase inhibitors; arachidonate 15-Lipoxygenase inhibitors; 15-Lipoxygenase Inhibitors, Arachidonate; Arachidonate 15 Lipoxygenase Inhibitors; Inhibitors, Arachidonate 15-Lipoxygenase; 15-Lipoxygenase Inhibitors; 15 Lipoxygenase Inhibitors; Inhibitors, 15-Lipoxygenase; 5-Lipoxygenase Inhibitors, Arachidonate; Arachidonate 5 Lipoxygenase Inhibitors; Inhibitors, Arachidonate 5-Lipoxygenase; 5-Lipoxygenase Inhibitors; 5 Lipoxygenase Inhibitors; Inhibitors, 5-Lipoxygenase; 12-Lipoxygenase Inhibitors, Arachidonate; Arachidonate 12 Lipoxygenase Inhibitors; Inhibitors, Arachidonate 12-Lipoxygenase; 12-Lipoxygenase Inhibitors; 12 Lipoxygenase Inhibitors; Inhibitors, 12-Lipoxygenase; 5-Lipoxygenase Inhibitor; 5 Lipoxygenase Inhibitor; Inhibitor, 5-Lipoxygenase;

Wikipedia link : https://en.wikipedia.org/wiki/Lipoxygenase inhibitors;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D016859;

UMLS CUI

C0085385;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 5-lipoxygenase inhibitor (disposition) [SNOMED CT concept]
- Arachidonate 5-lipoxygenase inhibitor (disposition) [SNOMED CT concept]
- Product containing 5-lipoxygenase inhibitor (product) [SNOMED CT concept]
- Substance with arachidonate 5-lipoxygenase inhibitor mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Lipooxygenase Inhibitor [NCIt concept]
- Substance with 5-lipoxygenase inhibitor mechanism of action (substance) [SNOMED CT concept]
Indexing information
- (2-fluorobenzyl)-(2-methyl-2-phenyl-2H-chromen-6-yl-amine) [MeSH Supplementary Concept]
- (Z)-2-amino-1,5-dihydro-1-methyl-5-(4-(mesyl)benzylidene)-4H-imidazol-4-one mesilate [MeSH Supplementary Concept]
- 2-(4-(3-biphenyloxypropoxy)phenylthio)hexanoic acid [MeSH Supplementary Concept]
- 2-(4-(biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid [MeSH Supplementary Concept]
- 2-(4-chlorophenyl)-5-(4-methoxybenzylidene)-5H-thiazol-4-one [MeSH Supplementary Concept]
- 4-(3-((3-fluoro-4-(1-methyl-1H-pyrazol-5-yl)phenyl)thio)phenyl)tetrahydro-2H-pyran-4-carboxamide [MeSH Supplementary Concept]
- 4-(5-chloro-3-(cyclohexylamino)imidazo(1,2-a)pyridin-2-yl)-2-methoxyphenol [MeSH Supplementary Concept]
- 5-propyl-3-(4-propylphenoxy)benzene-1,2-diol [MeSH Supplementary Concept]
- 6'-hydroxyoxosorbicillinol [MeSH Supplementary Concept]
- CGS 5677 [MeSH Supplementary Concept]
- KYKZL-1 compound [MeSH Supplementary Concept]
- LP105 compound [MeSH Supplementary Concept]
- LY 270766 [MeSH Supplementary Concept]
- RHC 5901 [MeSH Supplementary Concept]
- UP446 [MeSH Supplementary Concept]
- dammara-20,24-dien-3-one [MeSH Supplementary Concept]
- ethyl 4-(benzyloxy)-3-((3-(4-methoxytetrahydro-2H-pyran-4-yl)phenyl)methylsulfonamido)benzoate [MeSH Supplementary Concept]
- setileuton [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- arachidonate 12-lipoxygenase [MeSH Descriptor]
- arachidonate 15-lipoxygenase [MeSH Descriptor]
- arachidonate 5-lipoxygenase [MeSH Descriptor]
- lipoxygenase [MeSH Descriptor]
- lipoxygenases [MeSH Descriptor]
Record concept(s)
- arachidonate 12-Lipoxygenase inhibitors [MeSH concept]
- arachidonate 15-Lipoxygenase inhibitors [MeSH concept]
- arachidonate 5-Lipoxygenase inhibitors [MeSH concept]
- lipoxygenase inhibitors [MeSH concept]
See also (suggested by CISMeF)
- lipoxygenase [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- ((E)-(5)-(3,5-di-tert-butyl-4-hydroxybenzylidene)- 2-ethyl-1,2-isothiazolidine-1,1-dioxide) [MeSH Supplementary Concept]
- 1,6-dimethyl-2-(4'-N-n-propylsuccinamido)methyl-3-hydroxypyridin-4(1H)-one [MeSH Supplementary Concept]
- 1-phenylperhydro-1,2,4-triazin-3-one [MeSH Supplementary Concept]
- 12-labdene-15,16,(8)17-trial [MeSH Supplementary Concept]
- 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid [MeSH Supplementary Concept]
- 2',5'-dimethoxy-3,4-dihydroxychalcone [MeSH Supplementary Concept]
- 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone [MeSH Supplementary Concept]
- 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid [MeSH Supplementary Concept]
- 2-(4-aminophenyl)-3-(3,5-dihydroxylphenyl)propenoic acid [MeSH Supplementary Concept]
- 2-(4-hydroxyphenyl)-3-(3,5-dihydroxyphenyl)propenoic acid [MeSH Supplementary Concept]
- 3-(5-hydroxy-4,6,7-trimethyl-1,3-benzoxathiazol-2-yl)propanol [MeSH Supplementary Concept]
- 3-oxo-tirucall-8,24-dien-21-oic acid [MeSH Supplementary Concept]
- 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine [MeSH Descriptor]
- 4-(2-oxapentadeca-4-yne)phenylpropanoic acid [MeSH Supplementary Concept]
- 4-(5-fluoro-3-(4-(2-methyl-1H-imidazol-1-yl)benzyloxy)phenyl)-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide [MeSH Supplementary Concept]
- 4-(5-fluoro-3-(4-(2-methyl-1H-imidazol-1-yl)benzyloxy)phenyl)-4-methoxy-3,4,5,6-tetrahydro-2H-pyran [MeSH Supplementary Concept]
- 4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one [MeSH Supplementary Concept]
- 5-(N-hydroxy-N-(1-(2-(3,4,5-trimethoxyphenyl)-5-benzofuranyl)ethyl)amino)-5-oxopentanoate [MeSH Supplementary Concept]
- 5-Loxin [MeSH Supplementary Concept]
- 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate [MeSH Supplementary Concept]
- 9-hydroperoxy-11,12-octadecadienoic acid [MeSH Supplementary Concept]
- CMI 392 [MeSH Supplementary Concept]
- L 670630 [MeSH Supplementary Concept]
- L 708780 [MeSH Supplementary Concept]
- LQFM-091 [MeSH Supplementary Concept]
- LY 178002 [MeSH Supplementary Concept]
- MK-886 [MeSH Supplementary Concept]
- N-(3-phenoxycinnamyl)acetohydroxamic acid [MeSH Supplementary Concept]
- N-4-(4-fluorophenylaminosulfonyl)benzoisoselenothiazolidone [MeSH Supplementary Concept]
- N-4-(4-methoxyphenylaminosulfonyl)benzoisoselenothiazolidone [MeSH Supplementary Concept]
- N-hydroxy-N-(1-(2-phenyl-5-benzofuranyl)ethyl)furancarboxamide [MeSH Supplementary Concept]
- N-hydroxy-N-(1-(2-phenylbenzofuran-5-yl)ethyl)urea [MeSH Supplementary Concept]
- N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide [MeSH Supplementary Concept]
- N-linoleoyldopamine [MeSH Supplementary Concept]
- S 29606 [MeSH Supplementary Concept]
- S 30621 [MeSH Supplementary Concept]
- S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid [MeSH Supplementary Concept]
- alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol [MeSH Supplementary Concept]
- atreleuton [MeSH Supplementary Concept]
- azelastine [MeSH Supplementary Concept]
- benoxaprofen [MeSH Supplementary Concept]
- camelliaside C [MeSH Supplementary Concept]
- chebulagic acid [MeSH Supplementary Concept]
- diethylcarbamazine [MeSH Descriptor]
- licofelone [MeSH Supplementary Concept]
- masoprocol [MeSH Descriptor]
- nafazatrom [MeSH Supplementary Concept]
- ocobullenone [MeSH Supplementary Concept]
- oxphaman [MeSH Supplementary Concept]
- phenidone [MeSH Supplementary Concept]
- piriprost [MeSH Supplementary Concept]
- tetrapetalone B [MeSH Supplementary Concept]
- tetrapetalone C [MeSH Supplementary Concept]
- tetrapetalone D [MeSH Supplementary Concept]
- wy 45911 [MeSH Supplementary Concept]
- zileuton [MeSH Supplementary Concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients